MktsMarkets

Zentalis Pharmaceuticals, Inc.
NASDAQ: ZNTLKey statistics
ZNTL News
Stories mentioning ZNTL from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 26,865 | 0.00 | 0.00 | |
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | |||||||
| Operating Expenses | ||||||||
| Research & Development | 28,716 | 29,488 | 22,950 | 27,610 | 27,247 | 32,973 | 36,824 | 48,386 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 37,855 | 37,393 | 33,734 | 36,058 | 45,623 | 76,714 | 51,432 | 65,148 |
| Operating Income (Loss) | (37,855) | (37,393) | (33,734) | (36,058) | (45,623) | (49,849) | (51,432) | (65,148) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (35,232) | (34,774) | (26,691) | (26,874) | (48,279) | (47,677) | (40,185) | (88,011) |
| Tax Provision | 120.00 | 442.00 | 0.00 | 0.00 | 0.00 | (205.00) | (27.00) | 266.00 |
| Net Income (Loss) | (35,352) | (35,216) | (26,691) | (26,874) | (48,279) | (47,472) | (40,158) | (88,277) |
| Earnings Per Share (Basic) | (0.50) | (0.49) | (0.37) | (0.37) | (0.67) | (0.67) | (0.56) | (1.24) |
| Earnings Per Share (Diluted) | (0.50) | (0.49) | (0.37) | (0.37) | (0.67) | (0.67) | (0.56) | (1.24) |
| Weighted Average Shares Outstanding (Basic) | 70,264 | 71,869 | 72,139 | 71,992 | 71,678 | 71,080 | 71,111 | 71,040 |
| Weighted Average Shares Outstanding (Diluted) | 70,264 | 71,869 | 72,139 | 71,992 | 71,678 | 71,080 | 71,111 | 71,040 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ZNTL
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) is a stock listed on the Nasdaq Stock Market under the ticker symbol ZNTL. It last traded at $1.70 (Nov 13, 2026, 9:30 AM ET), up 1.2% on the day. That gives Zentalis Pharmaceuticals a market capitalisation of $186.6M.
Over the past 52 weeks ZNTL has traded between $1.28 and $6.95.
For the quarter ended Mar 31, 2026 it reported a net loss of $35.4M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$35.4M |
| Dec 31, 2025 | $0 | -$35.2M |
| Sep 30, 2025 | $0 | -$26.7M |
| Jun 30, 2025 | $0 | -$26.9M |
From Zentalis Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…